Drug Development in the Prevention and Treatment of COVID-19
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 71
Special Issue Editors
Interests: public health; infectious diseases; COVID-19; occupational medicine; drug development
2. Azienda Policlinico Umberto I, 00161 Rome, Italy
Interests: HIV; nutrition; probiotics; microbiota; immune response; gender; quality of life; NCCD
Special Issues, Collections and Topics in MDPI journals
Interests: hospital acquired infections; MDR infections; STD; special populations and migrants
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Infectious disease (ID) control represents a focus of global health policy, as IDs are significantly associated with morbidity and mortality and are among the top leading causes of death worldwide. The emergence of new bacteria and viruses, such as SARS-CoV-2, has been identified as a threat to global public health with a high economic and social burden. Although enormous progress has been made in knowledge, prevention, and antimicrobial therapy, minimizing the human and economic cost of IDs, even before the COVID-19 pandemic, was a special challenge for public health. To date, despite the availability of anti-infectious therapies, antimicrobial resistance threatens the efficacy of several current antimicrobial agents. In addition, the unclear pathogenesis and host-related adverse reactions hinder the discovery of novel anti-infectious therapeutics. The update on research advances in IDs focusing on mechanistic topics is pivotal in order to identify preventive and therapeutic strategies aimed at minimizing the impact of IDs. The research on the present topic is of particular interest, but at the same time challenging, since it deals with new horizons for infectious disease research.
Prof. Dr. Gabriele D’Ettorre
Dr. Gabriella D’Ettorre
Dr. Giancarlo Ceccarelli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial therapy
- antimicrobial resistance
- preventive strategies
- precision medicine
- drug development
